Pharma-Q Cimetidine Injection 200 mg/2 ml Solution for injection.
PDF Leaflet Revision Date: 29 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastric and duodenal ulcers, oesophageal reflux, Zollinger-Ellison syndrome.
Dosage (summary)
Adults: 200 mg IV every 4-6 hours; max 2.4 g/day.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; safety not established.
Key Drug Interactions
- Warfarin
- Phenytoin
- Theophylline
- Ciclosporin
Contraindications
- Hypersensitivity to cimetidine
- Under 1 year of age
- Pregnancy
- Lactation
Common side effects
- Headache
- Dizziness
- Diarrhoea
- Skin rashes
Counselling Points
- Avoid hazardous tasks until effects are known.
- Monitor for signs of adverse reactions.
- Report any unusual symptoms.
Serious warnings
- Risk of cardiac arrest with rapid IV injection
- May mask gastric cancer symptoms
- Increased risk of pneumonia in certain patients
Important Disclaimer
The Pharma-Q Cimetidine Injection 200 mg/2 ml Solution for injection. professional information leaflet below is the property of Pharma-Q Holdings and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
